Proceedings of the PSK Conference (대한약학회:학술대회논문집)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

A newly antiarrhythmic drug CW-2202 is ideal in treating atrial fibrillation

  • Eun, Jae-Soon (College of Pharmacy, Woosuk University) ;
  • Kim, Dae-Keun (Dept. of Pharmacology, Chonbuk National Unviersity Medical School) ;
  • Chae, Soo-Wan (Dept. of Pharmacology, Chonbuk National Unviersity Medical School) ;
  • Kwak, Yong-Geun (Dept. of Pharmacology, Chonbuk National Unviersity Medical School)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

A number of patients suffering from atrial fibrillation are increasing and many cardiologists are trying to develop the ideal antiarrhythmic drugs for atrial fibrillation. Previously, we found out that CW-2202, a furanocoumarin derivative inhibited the hKvl.5 current expressing predominantly in human atrium without affecting the HERG current expressing mainly in ventricle. (omitted)

Keywords